Transcript levels of DNA methyltransferases DNMT1, DNMT3A and DNMT3B in CD4+ T cells from patients with systemic lupus erythematosus - PubMed (original) (raw)

Transcript levels of DNA methyltransferases DNMT1, DNMT3A and DNMT3B in CD4+ T cells from patients with systemic lupus erythematosus

Eva Balada et al. Immunology. 2008 Jul.

Abstract

Global DNA hypomethylation in CD4(+) T cells has been detected in systemic lupus erythematosus (SLE) and it seems to be linked to its pathogenesis. We investigated the relationship between overall DNA methylation and the expression of three DNA (cytosine-5) methyltransferases involved in the DNA methylation process. The DNA deoxymethylcytosine (dmC) content of purified CD4(+) T cells from 29 SLE patients and 30 healthy controls was measured by means of an enzyme-linked immunosorbent assay (ELISA). The transcript levels of DNA cytosine-5-methyltransferase 1 (DNMT1), DNA cytosine-5-methyltransferase 3A (DNMT3A) and DNA cytosine-5-methyltransferase 3B (DNMT3B) were quantified by real-time reverse transcription-polymerase chain reaction (RT-PCR). Association studies were also carried out with several laboratory parameters, as well as with the patients' clinical manifestations. SLE patients had a significantly lower CD4(+) T-cell DNA dmC content than controls (0.802 +/- 0.134 versus 0.901 +/- 0.133) (P = 0.007). No differences in transcript levels were observed for DNMT1, DNMT3A and DNMT3B between patients and controls. The simultaneous association of low complement counts with lymphopenia, high titres of anti-double-stranded DNA (anti-dsDNA), or an SLE disease activity index (SLEDAI) of > 5, resulted in the increase of at least one of the three DNA methyltransferases. It is possible that patients were reacting indirectly to an underlying DNA hypomethylation status by increasing the mRNA levels of DNA methyltransferases when the disease was being definitely active.

PubMed Disclaimer

Figures

Figure 1

Correlation between methylation indices and normalized levels of DNA cytosine-5-methyltransferase 1 (DNMT1), DNA cytosine-5-methyltransferase 3A (DNMT3A) and DNA cytosine-5-methyltransferase 3B (DNMT3B) in healthy controls (a) and in patients with systemic lupus erythematosus (SLE) (b). Statistically significant values are marked with an asterisk.

Figure 2

Inverse correlation between methylation indices and the levels of normalized DNA cytosine-5-methyltransferase 1 (DNMT1) in five patients from whom one or two more samples were obtained after the moment (indicated by number 1) in which they were included as patients suffering from a clinical systemic lupus erythematosus (SLE) flare.

References

1. Razin A, Riggs AD. DNA methylation and gene function. Science. 1980;210:604–10. - PubMed
1. Jones PA, Taylor SM. Cellular differentiation, cytidine analogs and DNA methylation. Cell. 1980;20:85–93. - PubMed
1. Li E. Role of DNA methylation in development. In: Reik W, Surani A, editors. Genomic Imprinting: Frontiers in Molecular Biology. Oxford: IRL Press; 1997. pp. 1–20.
1. Jähner D, Jaenisch R. DNA methylation in early mammalian development. In: Razin A, Cedar H, Riggs A, editors. DNA Methylation: Biochemistry and Biological Significance. New York: Springer-Verlag; 1984. pp. 189–219.
1. Brockdorff N. Convergent themes in X chromosome inactivation and autosomal imprinting. In: Reik W, Surani A, editors. Genomic Imprinting: Frontiers in Molecular Biology. Oxford: IRL Press; 1997. pp. 191–210.

Transcript levels of DNA methyltransferases DNMT1, DNMT3A and DNMT3B in CD4+ T cells from patients with systemic lupus erythematosus - PubMed (original) (raw)